Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is ependymoma?
Ependymoma is a tumor that arises from ependymal cells, the thin layer of cells that line the fluid-filled spaces (ventricles) of the brain and the central canal of the spinal cord. It can occur anywhere along this lining — most often in the back of the brain (the posterior fossa) in children, and more often in the spinal cord in adults. Because these tumors grow near the flow of cerebrospinal fluid, they can block that flow and raise pressure inside the head, causing headaches, nausea, and balance problems; spinal ependymomas can cause back pain, weakness, or numbness. Ependymomas range from slower-growing to more aggressive, and their behavior depends heavily on where they are located and their molecular features, which doctors now use to classify them more precisely. The single most important factor in the outlook is how completely the tumor can be surgically removed, so the goal of surgery is a complete removal whenever it can be done safely. Most patients then receive focused radiation to the tumor area to reduce the chance of regrowth. Unlike medulloblastoma, most ependymomas do not require radiation to the whole brain and spine unless imaging or spinal-fluid testing shows the tumor has spread. Care is delivered by a team that may include neurosurgeons, radiation oncologists, neuro-oncologists, and, for children, pediatric specialists, with an emphasis on long-term control and quality of life.
The main types
Doctors group ependymoma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Posterior fossa ependymoma | Grows in the lower back part of the brain, most common in children; can press on the brainstem and block fluid flow, so complete surgical removal followed by focused radiation is key. |
| Supratentorial ependymoma | Grows in the upper part of the brain; molecular features (such as certain gene fusions) help predict behavior and guide treatment. |
| Spinal ependymoma | Grows within or around the spinal cord, more common in adults; many are slower-growing and are often well controlled with surgery, sometimes followed by radiation. |
| Myxopapillary ependymoma | A distinct, usually slower-growing type found at the lower end of the spine; surgery is the mainstay, with radiation added when removal is incomplete or it recurs. |
Staging, in plain terms
Ependymoma is not described by the TNM stage numbers used for many adult cancers. Instead, doctors characterize it in several ways that guide treatment and predict outlook. The first is the grade, which reflects how aggressive the tumor looks under the microscope, ranging from slower-growing to more aggressive. The second is the location — in the brain or the spine, and exactly where — because location affects both the symptoms and how completely the tumor can be removed. The third, and increasingly important, factor is the tumor's molecular profile: specific genetic features now define distinct ependymoma types that behave differently and help refine the plan. Finally, and most importantly for the outlook, doctors assess how completely the tumor was removed at surgery: a complete removal carries a substantially better prognosis than a partial one. Doctors also check whether the tumor has spread through the cerebrospinal fluid by imaging the whole brain and spine and sometimes sampling the spinal fluid, because spread changes the radiation approach. Together, grade, location, molecular type, extent of removal, and any spread determine whether radiation is focused on the tumor area or, less commonly, extended to the whole brain and spine.
| Classified by grade, location, molecular features, and extent of removal — not TNM | What it generally means |
|---|---|
| Localized, completely removed | Tumor confined to one area and fully removed by surgery; usually followed by focused radiation to the tumor bed, with the best chance of long-term control. |
| Localized, partially removed | Tumor confined to one area but not fully removable; focused radiation treats the remaining tumor, and a second surgery is sometimes considered. |
| Disseminated | Tumor that has spread through the cerebrospinal fluid to other parts of the brain or spine; treated with radiation to the whole brain and spine plus a boost, and sometimes chemotherapy. |
The standard of care
Ependymoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Surgery (maximal safe removal)
Removing as much of the tumor as can be done safely — ideally all of it — is the most important step and the strongest predictor of a good outcome.
Focused radiation to the tumor bed
After surgery, precise radiation to the area where the tumor was greatly lowers the chance of regrowth and is standard for most brain ependymomas, even when the tumor was completely removed.
Craniospinal radiation for spread
If imaging or spinal-fluid testing shows the tumor has spread, radiation is extended to the whole brain and spine, with an added boost to the main tumor site.
Observation for selected spinal tumors
Some slower-growing spinal ependymomas that are completely removed may be watched closely with scans rather than treated with immediate radiation.
Chemotherapy in selected cases
Chemotherapy is used mainly in very young children to delay radiation, or in research settings, as ependymoma is generally less responsive to chemotherapy than some other brain tumors.
How radiation treatment works
Radiation therapy uses focused high-energy beams to damage the DNA inside cancer cells so they can no longer grow and divide. For ependymoma, radiation plays a central role after surgery because even when a tumor is completely removed, microscopic cells can remain at the edges and cause the tumor to return. Focused radiation to the area where the tumor was — the tumor bed — significantly lowers that risk and is standard for most brain ependymomas. The key principle is precision: ependymomas often sit close to critical structures such as the brainstem, the optic pathways, and the spinal cord, so the dose must be shaped tightly around the target while sparing these delicate tissues. Modern techniques such as intensity-modulated radiation therapy and, increasingly, proton therapy make this possible. Protons are especially useful in children because a proton beam stops at a controlled depth, sparing the developing brain and other organs beyond the tumor and helping to limit long-term effects on thinking and growth. Most ependymomas are treated with radiation focused on the tumor area alone, because unlike some other brain tumors they usually do not spread widely through the cerebrospinal fluid. However, if imaging or a sample of the spinal fluid shows the tumor has spread, radiation is extended to the whole brain and spinal cord, with an added boost to the main site. Your radiation oncologist plans the dose and technique carefully based on the tumor's location, grade, molecular features, and how completely it was removed, aiming for the best control while protecting healthy tissue.
The main ways radiation is delivered for ependymoma:
Intensity-modulated radiation therapy (IMRT)
Shapes the radiation dose tightly around the tumor area while sparing nearby brain, brainstem, and spinal cord, the standard way to treat the tumor bed after surgery.
Proton therapy
Proton beams stop at a set depth, sparing healthy brain and other organs beyond the target — especially valuable in children to protect the developing brain and reduce long-term effects.
Stereotactic radiosurgery
Delivers a high, precise dose in one or a few sessions to small or recurrent tumors, used in selected situations where a focused treatment is appropriate.
Craniospinal irradiation
Treats the entire brain and spinal cord when the tumor has spread through the cerebrospinal fluid, followed by a focused boost to the original tumor area.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Focused radiation after surgery improves control: Studies showed that giving precise radiation to the tumor bed after surgery substantially reduces the chance of ependymoma returning, establishing it as standard even for many completely removed brain tumors.[1]
Postoperative ependymoma radiation trials
Molecular classification refines outlook: Research identified distinct molecular types of ependymoma defined by their genetic features, which behave very differently and are now used to predict prognosis and tailor how aggressively each tumor is treated.[2]
Ependymoma molecular subgrouping studies
Proton therapy spares the developing brain: Studies in children found that proton radiation delivers effective tumor control while reducing dose to healthy brain and other tissues, helping to limit long-term effects on cognition and growth.[3]
Pediatric proton ependymoma outcomes
Common questions
Why do I need radiation if the whole tumor was removed? Even after a complete removal, microscopic tumor cells can remain at the edges of where the tumor was, and ependymoma has a real tendency to come back in that area. Focused radiation to the tumor bed substantially lowers that risk, which is why it is standard for most brain ependymomas even after a full removal.
Does ependymoma always need radiation to the whole brain and spine? Usually not. Most ependymomas are treated with radiation focused only on the area where the tumor was, because they typically do not spread widely. Radiation to the entire brain and spine is reserved for cases where imaging or spinal-fluid testing shows the tumor has spread.
What matters most for the outlook? How completely the tumor can be removed by surgery is the single most important factor — a complete removal carries a much better outlook. Location, grade, molecular features, and whether the tumor has spread also shape the plan and the prognosis.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.